Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early development of anti-drug antibodies to biologics in rheumatoid arthritis
NL-OMON25457Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in rheumatoid arthritis (RA), sponsored by Amsterdam University Medical Center. Primary endpoint: Early anti-drug specific B-cell immunization. Started Apr 2016; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON25457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25457.